Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bit Origin Raises $500M to Build Dogecoin Treasury Strategy

Bit Origin Raises $500M to Build Dogecoin Treasury Strategy

CryptotaleCryptotale2025/07/17 23:45
By:Victor
Bit Origin Raises $500M to Build Dogecoin Treasury Strategy image 0
  • Bit Origin secures $500M to build a Dogecoin treasury and boost adoption in digital payments.
  • The company has secured an initial $15M and will use part of it to start purchasing Dogecoin.
  • Dogecoin price climbs as Bit Origin commits $500M to treasury and payment ecosystem growth.

Bit Origin Ltd (NASDAQ: BTOG) announced it has secured agreements with accredited investors to raise $500 million. The funds will come from $400 million in Class A ordinary shares and $100 million in convertible debt. The company plans to use these proceeds to launch a Dogecoin treasury strategy aimed at making Bit Origin one of the largest publicly traded Dogecoin holders. 

Shares of Bit Origin surged 28% in early U.S. trading, reflecting investor interest in the company’s new direction. The Singapore-based crypto mining company, which has been publicly traded since 2019, has struggled, with its share price dropping nearly 100% since listing. Despite the decline, the announcement signifies a strategic shift toward using the increasing utility and support in the Dogecoin community.

Bit Origin’s Strategic Focus on Dogecoin and Payment Integration

The CEO and Chairman of Bit Origin, Jinghai Jiang, stressed that the company is no longer a mining infrastructure provider but a player directly participating in the value and utility of digital assets. Jiang highlighted fast settlement time and a massive community as essential aspects in adopting Dogecoin in peer-to-peer payments and online commerce. 

The company believes that Dogecoin naturally fits into the new payment layers, including those proposed by Elon Musk on his X Money platform. The treasury strategy aligns with Bit Origin’s philosophy that Dogecoin is a grassroots currency, deriving its strength from low transaction costs and increased merchant acceptance. 

The company intends to use its current blockchain infrastructure to develop new revenue channels. These channels will consist of miner-side services and payment apps in the Dogecoin ecosystem. The goal of these projects will be to drive long-term value to the network by spending on Dogecoin per share.

Fundraising Progress and Market Context

Moreover, Bit Origin has completed an initial debt closing of $15 million and plans to use a significant portion to acquire its first Dogecoin assets. Chardan served as the placement agent for the funding facility arranged by ATW Partners. The company’s public filings, including its Form 6-K dated July 17, 2025, provide further details on the fundraising terms and forward-looking statements.

Related: Ethereum Treasuries Surge as BitMine, BTCS Lead New Strategy

The announcement comes in the wake of a broader trend by publicly traded firms that have seen publicly traded companies accumulating cryptocurrency reserves on their balance sheets. Bit Origin is one of the few companies currently targeting Dogecoin. This memecoin has achieved legitimacy as a liquid digital asset that is backed by the support of a passionate community and growing merchant adoption.

Although Dogecoin emerged as a joke coin, its presence in the market has grown as it is now fast in transaction processing and has a significant social backing. At press time, Dogecoin is trading at $0.24, representing a 14.36% increase in the last 24 hours, indicating steady market activity. 

Bit Origin Raises $500M to Build Dogecoin Treasury Strategy image 1 Source: CoinMarketCap

The recent announcement by Bit Origin of a new strategy for the Dogecoin treasury demonstrates the increasing institutional attention to the possibility of adopting memecoins as long-term financial instruments. This integration of Dogecoin with payment platforms and blockchain infrastructure aims to capitalize on Dogecoin’s unique position in the crypto ecosystem.

The post Bit Origin Raises $500M to Build Dogecoin Treasury Strategy appeared first on Cryptotale.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales